Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OBAI compared with DARE: revenue, margins and what each company keeps, and the suppliers and customers both name
OBAI
Our Bond, Inc.
Change
Mkt cap
Revenue
Revenue
DARE
Dare Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
OBAI
Our Bond, Inc.
vs
DARE
Dare Bioscience, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
OBAI
Our Bond, Inc.
Change
1.68
▼
−5.62%
· post 1.68
· delayed
Mkt cap
$2.2M
Revenue
$2M
Q2 FY26
DARE
Dare Bioscience, Inc.
Change
0.65
▲
+4.10%
· post 0.63
· delayed
After hours
Nov 6 '26
delayed
Mkt cap
$9.5M
Revenue
$187,546
Q2 FY26
vs
Compare
After hours
Nov 6 '26
delayed
OBAI
Our Bond, Inc.
vs
DARE
Dare Bioscience, Inc.
1.68
▼
−5.62%
post 1.68
delayed
Price
0.65
▲
+4.10%
post 0.63
delayed
$2.2M
Mkt cap
$9.5M
Q2 FY26
$2M
Revenue
$187,546
Q2 FY26
Change
Change
OBAI
1.68
▼
−5.62%
vs
DARE
0.65
▲
+4.10%
After hours
Nov 6 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
OBAI: latest quarter is a loss; flow not drawable. DARE: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
OBAI, solid
DARE, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OBAI
1
—
largest customer
unlisted
customer
Shared
0
No shared counterparties.
Only DARE
5
OGN
Organon
customer
—
Bravado Pharmaceuticals
unlisted
supplier
—
Catalent JNP
unlisted
supplier
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Medvantx
unlisted
supplier
1 more · DARE chain
›